TABLE 6.
Formulation code | Particle size (nm) | Polydispersity index–PI | Zeta potential (mV) | Drug loading (%) | Encapsulation efficiency (%) |
E1 | 1631*** | 0.170.02 | −14.11.1 | 2.50.2 | 24.31.7 |
E2 | 1144*** | 0.170.04 | −11.61.3 | 2.80.4* | 27.33.6 |
E3 | 1332 | 0.200.03 | −10.12.0 | 2.20.3 | 23.23.7 |
E4 | 1371 | 0.200.03 | −12.60.3 | 1.20.1** | 12.60.5** |
E5 | 1291 | 0.160.07 | −13.53.5 | 1.30.1** | 13.40.9** |
Results are expressed as mean ± S.D (n = 3). *signifies p < 0.05, **signifies p < 0.01, ***signifies p < 0.001 significant differences with respect to E3 formulation. E1, PVA 1% w/v, E2, PVA 2% w/v, E3, PVA 2.5% w/v, E4, PVA 3% w/v, E5, PVA 4% w/v.